[Consensus guideline on tuberculosis and treatment of inflammatory bowel disease with infliximab. Spanish Working Group on Crohn Disease and Ulcerative Colitis]

Gastroenterol Hepatol. 2003 Jan;26(1):29-33. doi: 10.1016/s0210-5705(03)70338-0.
[Article in Spanish]
No abstract available

Publication types

  • Consensus Development Conference
  • Guideline
  • Practice Guideline
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy
  • Diagnosis, Differential
  • Disease Susceptibility
  • Female
  • Global Health
  • HIV Infections / complications
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Inflammatory Bowel Diseases / complications
  • Inflammatory Bowel Diseases / diagnosis
  • Inflammatory Bowel Diseases / drug therapy*
  • Infliximab
  • Male
  • Middle Aged
  • Opportunistic Infections / etiology
  • Opportunistic Infections / prevention & control
  • Prevalence
  • Radiography
  • Severity of Illness Index
  • Spain / epidemiology
  • Tuberculin Test
  • Tuberculosis / epidemiology
  • Tuberculosis / etiology*
  • Tuberculosis / prevention & control
  • Tuberculosis, Gastrointestinal / diagnosis
  • Tuberculosis, Pulmonary / diagnostic imaging

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Infliximab